Cargando…
Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application
Friedreich ataxia (FRDA) is a rare genetic multisystem disorder caused by a pathological GAA trinucleotide repeat expansion in the FXN gene. The numerous drawbacks of historical cellular and rodent models of FRDA have caused difficulty in performing effective mechanistic and translational studies to...
Autores principales: | Maheshwari, Saumya, Vilema-Enríquez, Gabriela, Wade-Martins, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510273/ https://www.ncbi.nlm.nih.gov/pubmed/37726850 http://dx.doi.org/10.1186/s40035-023-00376-8 |
Ejemplares similares
-
New Insights into the Hepcidin-Ferroportin Axis and Iron Homeostasis in iPSC-Derived Cardiomyocytes from Friedreich's Ataxia Patient
por: Bolotta, Alessandra, et al.
Publicado: (2019) -
In vivo survival and differentiation of Friedreich ataxia iPSC‐derived sensory neurons transplanted in the adult dorsal root ganglia
por: Viventi, Serena, et al.
Publicado: (2021) -
Patient-derived iPSCs: a new model for Friedreich’s ataxia
Publicado: (2013) -
Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells
por: Vilema-Enríquez, Gabriela, et al.
Publicado: (2021) -
Quantitative Proteomic Analysis Identifies Targets and Pathways of a 2-Aminobenzamide HDAC Inhibitor in Friedreich’s Ataxia Patient iPSC-Derived Neural Stem Cells
por: Shan, Bing, et al.
Publicado: (2014)